SHELEAN ROYLANCE: Open Payments
NPI 1932301918 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 31 payments from 6 companies in 2025. Trend: 2023 $472 · 2024 $373 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $273 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $205 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Alexion Pharmaceuticals, Inc. | 2 | $60 |
| Novo Nordisk Inc | 3 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: JARDIANCE, VRAYLAR, ULTOMIRIS, UBRELVY, AIRSUPRA, BREZTRI, QULIPTA, Wegovy.
Industry payments across HI — which companies pay providers there.
